The U.S. FDA on Friday approved two gene therapies for sickle cell disease from Vertex Pharmaceuticals and CRISPR Therapeutics, as well as from bluebird bio.
4-time Olympic medallist Adam van Koeverden to oversee sport in PM Carney's new cabinet
- today, 2:13 PM
- cbc.ca
- 0
No comments